FDC

Market Cap: Mid Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE258B01022
NSEID: FDC
BSEID: 531599

INR

425.20

18.05 (4.43%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.02 lacs

{
  "main_header": {
    "sid": 248455,
    "name": "FDC",
    "stock_name": "FDC",
    "full_name": "FDC Ltd",
    "name_url": "stocks-analysis/fdc",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "425.20",
    "chg": 18.05,
    "chgp": "4.43%",
    "dir": 1,
    "prev_price": "407.15",
    "mcapval": "6,922.68 Cr",
    "mcap": "Mid Cap",
    "scripcode": 531599,
    "symbol": "FDC",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE258B01022",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "23:57 PM",
    "bse_nse_vol": "1.02 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fdc-248455-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "FDC Ltd Faces Significant Stock Decline Amid Broader Market Resilience",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-stock-declines-5-34-underperforming-pharmaceuticals-sector-and-broader-market-1609094",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/FDC_priceRelatedfactors_813473.png",
        "date": "2025-03-26 15:30:15",
        "description": "FDC Ltd, a midcap pharmaceutical company, has faced a notable decline in its stock price, underperforming against the broader market. The stock has dropped significantly over the past two days and is currently trading below key moving averages, indicating ongoing challenges despite a resilient market overall."
      },
      {
        "title": "FDC Ltd Shows Mixed Momentum Amid Broader Market Gains and Long-Term Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-stock-rises-5-28-despite-mixed-performance-and-strong-sell-rating-1206885",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/FDC_priceRelatedfactors_594556.png",
        "date": "2025-03-05 15:50:15",
        "description": "FDC Ltd, a midcap pharmaceutical company, experienced significant intraday gains, outperforming the broader market. While the stock is above its 5-day moving average, it remains below several longer-term averages. Despite recent challenges, FDC has shown notable appreciation over the past three years compared to the Sensex."
      },
      {
        "title": "FDC Ltd Faces Continued Market Challenges Amid Significant Stock Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-hits-52-week-low-as-stock-declines-9-15-over-six-days-1172681",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/FDC_priceRelatedfactors_562523.png",
        "date": "2025-03-03 10:35:24",
        "description": "FDC Ltd, a midcap pharmaceutical company, reached a new 52-week low today amid ongoing market challenges, reflecting a cumulative drop of 9.15% over the past six days. The stock is trading below all key moving averages and has declined 16.50% annually, underperforming compared to the Sensex."
      },
      {
        "title": "FDC Adjusts Valuation Grade Amidst Competitive Industry Landscape and Market Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fdcs-valuation-grade-adjusted-from-expensive-to-fair-amid-stock-price-decline-2-1154008",
        "imagepath": "",
        "date": "2025-03-01 08:00:20",
        "description": "FDC, a midcap player in the Pharmaceuticals & Drugs sector, has recently undergone a valuation adjustment. The company's current price stands at 376.80, reflecting a decline from its previous close of 389.25. Over the past year, FDC has experienced a stock return of -15.24%, contrasting with a modest gain of 1.24% in the Sensex.\n\nKey financial metrics for FDC include a price-to-earnings (PE) ratio of 22.36 and an EV to EBITDA ratio of 17.40. The company also boasts a return on capital employed (ROCE) of 18.11% and a return on equity (ROE) of 13.81%. Additionally, FDC offers a dividend yield of 1.33%, which may appeal to income-focused investors.\n\nIn comparison to its peers, FDC's valuation metrics present a more favorable picture. For instance, Emcure Pharma and Wockhardt are positioned at higher valuation levels, while AstraZeneca and Pfizer are categorized as significantly more expensive. This context hig..."
      },
      {
        "title": "FDC Ltd Faces Ongoing Market Challenges Amid Significant Stock Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-hits-52-week-low-at-rs-380-35-amid-ongoing-stock-decline-1139628",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/FDC_priceRelatedfactors_547226.png",
        "date": "2025-02-28 09:35:37",
        "description": "FDC Ltd, a midcap pharmaceutical company, has reached a new 52-week low amid ongoing market challenges, underperforming its sector. The stock has declined 14.49% over the past year, contrasting with the Sensex's gains, and is currently trading below key moving averages, indicating sustained underperformance."
      },
      {
        "title": "FDC Ltd Faces Continued Challenges Amid Significant Stock Volatility and Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-hits-52-week-low-at-rs-388-2-amid-ongoing-stock-decline-1130242",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/FDC_priceRelatedfactors_531682.png",
        "date": "2025-02-27 11:35:14",
        "description": "FDC Ltd, a midcap pharmaceutical company, has reached a new 52-week low amid significant volatility, underperforming its sector. The stock has faced consecutive losses over four days and is trading below key moving averages, reflecting ongoing challenges. Over the past year, FDC has declined notably compared to the Sensex."
      },
      {
        "title": "FDC Ltd Faces Significant Stock Volatility Amidst Sector Underperformance and Declining Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-stock-hits-52-week-low-amid-continued-decline-and-bearish-trend-1040286",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/FDC_priceRelatedfactors_451208.png",
        "date": "2025-02-17 09:45:16",
        "description": "FDC Ltd, a midcap pharmaceutical company, has hit a new 52-week low amid significant volatility, underperforming its sector. The stock has seen consecutive losses over the past week and is trading below key moving averages, raising concerns about its future positioning in the market."
      },
      {
        "title": "FDC Ltd Faces Significant Volatility and Underperformance Amid Market Challenges in October 2023",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-hits-52-week-low-at-rs-399-85-amid-significant-stock-decline-in-february-2025-997311",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/FDC_priceRelatedfactors_426458.png",
        "date": "2025-02-13 10:05:21",
        "description": "FDC Ltd, a midcap pharmaceutical company, has faced notable volatility, hitting a 52-week low of Rs. 399.85. The stock has declined 15.44% over the past five days and is underperforming its sector. Additionally, it has dropped 7.73% over the past year, contrasting with the Sensex's gains."
      },
      {
        "title": "FDC Ltd Faces Significant Stock Volatility Amid Broader Market Challenges in October 2023",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-stock-declines-6-97-amid-continued-underperformance-in-february-2025-996987",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/FDC_priceRelatedfactors_424947.png",
        "date": "2025-02-13 09:30:12",
        "description": "FDC Ltd, a midcap pharmaceutical company, faced significant stock volatility today, with a notable decline. The stock has underperformed its sector and is trading below key moving averages. It is nearing its 52-week low, while the broader market, represented by the Sensex, remains relatively stable."
      }
    ],
    "total": 73,
    "sid": "248455",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/fdc-248455"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2025",
      "details": "Intimation of closure of trading window with effect from April 01 2025",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "19-Feb-2025",
      "details": "Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "12-Feb-2025",
      "details": "Press release in relation to unaudited standalone and consolidated financial results for the quarter and nine months ended December 31 2024.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "FDC Ltd has declared <strong>500%</strong> dividend, ex-date: 22 Nov 24",
          "dt": "2024-11-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

FDC Ltd Faces Significant Stock Decline Amid Broader Market Resilience

2025-03-26 15:30:15

FDC Ltd, a midcap pharmaceutical company, has faced a notable decline in its stock price, underperforming against the broader market. The stock has dropped significantly over the past two days and is currently trading below key moving averages, indicating ongoing challenges despite a resilient market overall.

FDC Ltd Shows Mixed Momentum Amid Broader Market Gains and Long-Term Challenges

2025-03-05 15:50:15

FDC Ltd, a midcap pharmaceutical company, experienced significant intraday gains, outperforming the broader market. While the stock is above its 5-day moving average, it remains below several longer-term averages. Despite recent challenges, FDC has shown notable appreciation over the past three years compared to the Sensex.

FDC Ltd Faces Continued Market Challenges Amid Significant Stock Volatility

2025-03-03 10:35:24

FDC Ltd, a midcap pharmaceutical company, reached a new 52-week low today amid ongoing market challenges, reflecting a cumulative drop of 9.15% over the past six days. The stock is trading below all key moving averages and has declined 16.50% annually, underperforming compared to the Sensex.

FDC Adjusts Valuation Grade Amidst Competitive Industry Landscape and Market Fluctuations

2025-03-01 08:00:20

FDC, a midcap player in the Pharmaceuticals & Drugs sector, has recently undergone a valuation adjustment. The company's current price stands at 376.80, reflecting a decline from its previous close of 389.25. Over the past year, FDC has experienced a stock return of -15.24%, contrasting with a modest gain of 1.24% in the Sensex. Key financial metrics for FDC include a price-to-earnings (PE) ratio of 22.36 and an EV to EBITDA ratio of 17.40. The company also boasts a return on capital employed (ROCE) of 18.11% and a return on equity (ROE) of 13.81%. Additionally, FDC offers a dividend yield of 1.33%, which may appeal to income-focused investors. In comparison to its peers, FDC's valuation metrics present a more favorable picture. For instance, Emcure Pharma and Wockhardt are positioned at higher valuation levels, while AstraZeneca and Pfizer are categorized as significantly more expensive. This context hig...

FDC Ltd Faces Ongoing Market Challenges Amid Significant Stock Volatility

2025-02-28 09:35:37

FDC Ltd, a midcap pharmaceutical company, has reached a new 52-week low amid ongoing market challenges, underperforming its sector. The stock has declined 14.49% over the past year, contrasting with the Sensex's gains, and is currently trading below key moving averages, indicating sustained underperformance.

FDC Ltd Faces Continued Challenges Amid Significant Stock Volatility and Underperformance

2025-02-27 11:35:14

FDC Ltd, a midcap pharmaceutical company, has reached a new 52-week low amid significant volatility, underperforming its sector. The stock has faced consecutive losses over four days and is trading below key moving averages, reflecting ongoing challenges. Over the past year, FDC has declined notably compared to the Sensex.

FDC Ltd Faces Significant Stock Volatility Amidst Sector Underperformance and Declining Trends

2025-02-17 09:45:16

FDC Ltd, a midcap pharmaceutical company, has hit a new 52-week low amid significant volatility, underperforming its sector. The stock has seen consecutive losses over the past week and is trading below key moving averages, raising concerns about its future positioning in the market.

FDC Ltd Faces Significant Volatility and Underperformance Amid Market Challenges in October 2023

2025-02-13 10:05:21

FDC Ltd, a midcap pharmaceutical company, has faced notable volatility, hitting a 52-week low of Rs. 399.85. The stock has declined 15.44% over the past five days and is underperforming its sector. Additionally, it has dropped 7.73% over the past year, contrasting with the Sensex's gains.

FDC Ltd Faces Significant Stock Volatility Amid Broader Market Challenges in October 2023

2025-02-13 09:30:12

FDC Ltd, a midcap pharmaceutical company, faced significant stock volatility today, with a notable decline. The stock has underperformed its sector and is trading below key moving averages. It is nearing its 52-week low, while the broader market, represented by the Sensex, remains relatively stable.